Spelling suggestions: "subject:"chlamydiae"" "subject:"chlamydiale""
1 |
Thymidylate synthesis and folate metabolism by the obligate intracellular parasite Chlamydiae : metabolic studies and molecular cloningFan, Huizhou 02 October 2013 (has links)
Since host cell-derived thymidine is not incorporated into Chlamydia trachomatis
DNA, we hypothesized that chlamydiae must synthesize dTMF de novo for DNA
replication. The only known enzyme performing de novo dTMP synthesis is thymidylate
synthase (TS). The goals of this thesis were to provide biochemical evidence for the
existence of TS in chlamydiae, to investigate the mechanism by which the parasite
obtains folate, a necessary cofactor for TS, and to provisionally characterize chlamydial
TS. Results of a series of in situ experiments using a mutant cell line as chlamydial host
which is incapable of de novo dTMP synthesis suggest that C. trachomatis converts
dUMP into dTXP. In vitro experiments conclusively establish these findings by the
demonstration of TS activity in extracts prepared from host-free chlamydial reticulate
bodies. Furthermore it was found that both sulfa-sensitive and sulfa-resistant chlamydial
strains can synthesize folates de novo; however strains vary significantly in their ability
to transport preformed folates from the host cell. A C. trachomatis gene which is capable
of complementing thymidine auxotrophy in Escherichia coli deficient in TS was cloned.
Auxotrophic E. coli containing the complementing chlamydial DNA sequence converts
dUMP to dTMP, using methylene tetrahydrofolate as the cofactor. The complementing
DNA fragment contains an open reading frame of 1587 bp. Surprisingly this open
reading frame shows absence of sequence homology to known TS. Unique in vitro
characteristics shared by the enzyme activities from both chlamydial extract and
recombinant E. coli extract suggest that C. trachomatis might encode a novel TS.
|
2 |
Thymidylate synthesis and folate metabolism by the obligate intracellular parasite Chlamydiae : metabolic studies and molecular cloningFan, Huizhou 02 October 2013 (has links)
Since host cell-derived thymidine is not incorporated into Chlamydia trachomatis
DNA, we hypothesized that chlamydiae must synthesize dTMF de novo for DNA
replication. The only known enzyme performing de novo dTMP synthesis is thymidylate
synthase (TS). The goals of this thesis were to provide biochemical evidence for the
existence of TS in chlamydiae, to investigate the mechanism by which the parasite
obtains folate, a necessary cofactor for TS, and to provisionally characterize chlamydial
TS. Results of a series of in situ experiments using a mutant cell line as chlamydial host
which is incapable of de novo dTMP synthesis suggest that C. trachomatis converts
dUMP into dTXP. In vitro experiments conclusively establish these findings by the
demonstration of TS activity in extracts prepared from host-free chlamydial reticulate
bodies. Furthermore it was found that both sulfa-sensitive and sulfa-resistant chlamydial
strains can synthesize folates de novo; however strains vary significantly in their ability
to transport preformed folates from the host cell. A C. trachomatis gene which is capable
of complementing thymidine auxotrophy in Escherichia coli deficient in TS was cloned.
Auxotrophic E. coli containing the complementing chlamydial DNA sequence converts
dUMP to dTMP, using methylene tetrahydrofolate as the cofactor. The complementing
DNA fragment contains an open reading frame of 1587 bp. Surprisingly this open
reading frame shows absence of sequence homology to known TS. Unique in vitro
characteristics shared by the enzyme activities from both chlamydial extract and
recombinant E. coli extract suggest that C. trachomatis might encode a novel TS.
|
3 |
Chemical genetics discloses the importance of heme and glucose metabolism in Chlamydia trachomatis pathogenesisEngström, Patrik January 2013 (has links)
Chlamydiae are important human bacterial pathogens with an intracellular life cycle that consists of two distinct bacterial forms, an infectious form (EB) that infects the eukaryotic host cell, and a non-infectious form (RB) that allows intracellular proliferation. To be successful, chlamydiae need to alternate between EB and RB to generate infectious EB’s which are competent to infect new host cells. Chemical genetics is an attractive approach to study bacterial pathogenesis; in principal this approach relies on an inhibitory compound that specifically inhibits a protein of interest. An obstacle in using this approach is target identification, however whole genome sequencing (WGS) of spontaneous mutants resistant to novel inhibitory compounds has significantly extended the utility of chemical genetic approaches by allowing the identification of their target proteins and/or biological pathways. In this thesis, a chemical genetics approach is used, I have found that heme and glucose metabolism of C. trachomatis is specifically important for the transition from the RB form to the infectious EB form. Heme and glucose metabolism are both coupled to energy metabolism, which suggests a common link between the RB-to-EB transitions. In connection with the above findings I have developed strategies that enable the isolation of isogenic C. trachomatis mutant strains. These strategies are based on WGS of spontaneous mutant populations and subsequent genotyping of clonal strains isolated from these mutant populations. Experiments with the mutant strains suggest that the uptake of glucose-6-phosphate (G-6-P) regulates the RB-to-EB transition, representing one of the first examples where genetics has been used to study C. trachomatis pathogenesis. Additional experiments with the mutant strains indicate that G-6-P promotes bacterial growth during metabolic stress. In concert with other findings presented in this thesis, I have fine-tuned methods that could be employed to reveal how novel inhibitory chemical compounds affect chlamydiae. In a broader context, I suggest that C. trachomatis could be used as a model organism to understand how new inhibitory drugs affect other bacterial pathogens. In addition, I observed that C. pneumoniae infections resulted in generalized bone loss in mice and that these mice display a cytokine profile similar to infected bone cells in vitro. Thus, this study indicates that C. pneumoniae potentially can infect bone cells in vivo, resulting in bone loss, alternatively, the inflammatory responses seen in vivo could be the causative factor of the bone loss observed.
|
4 |
Commonly Prescribed β-lactam Antibiotics Induce C.trachomatis Persistence/Stress in Culture at Physiologically Relevant ConcentrationsKintner, Jennifer, Lajoie, Dawn, Hall, Jennifer, Whittimore, Judy, Schoborg, Robert V. 01 April 2014 (has links)
Chlamydia trachomatis, the most common bacterial sexually transmitted disease agent worldwide, enters a viable, non-dividing and non-infectious state (historically termed persistence and more recently referred to as the chlamydial stress response) when exposed to penicillin G in culture. Notably, penicillin G-exposed chlamydiae can reenter the normal developmental cycle upon drug removal and are resistant to azithromycin-mediated killing. Because penicillin G is less frequently prescribed than other ß-lactams, the clinical relevance of penicillin G-induced chlamydial persistence/stress has been questioned. The goal of this study was to determine whether more commonly used penicillins also induce C. trachomatis serovar E persistence/stress. All penicillins tested, as well as clavulanic acid, induced formation of aberrant, enlarged reticulate bodies (RB) (called aberrant bodies or AB) characteristic of persistent/stressed chlamydiae. Exposure to the penicillins and clavulanic acid also reduced chlamydial infectivity by >95%. None of the drugs tested significantly reduced chlamydial unprocessed 16S rRNA or genomic DNA accumulation, indicating that the organisms were viable, though non-infectious. Finally, recovery assays demonstrated that chlamydiae rendered essentially non-infectious by exposure to ampicillin, amoxicillin, carbenicillin, piperacillin, penicillin V, and clavulanic acid recovered infectivity after antibiotic removal. These data definitively demonstrate that several commonly used penicillins induce C. trachomatis persistence/stress at clinically relevant concentrations.
|
5 |
Porcine Epidemic Diarrhea Virus (PEDV) Co-Infection Induced Chlamydial Persistence/Stress Does Not Require Viral ReplicationSchoborg, Robert V., Borel, Nicole 01 January 2014 (has links)
Chlamydiae may exist at the site of infection in an alternative replicative form, called the aberrant body (AB). ABs are produced during a viable but non-infectious developmental state termed "persistence" or "chlamydial stress." As persistent/stressed chlamydiae: (i) may contribute to chronic inflammation observed in diseases like trachoma; and (ii) are more resistant to current anti-chlamydial drugs of choice, it is critical to better understand this developmental stage. We previously demonstrated that porcine epidemic diarrhea virus (PEDV) co-infection induced Chlamydia pecorum persistence/stress in culture. One critical characteristic of persistence/stress is that the chlamydiae remain viable and can reenter the normal developmental cycle when the stressor is removed. Thus, we hypothesized that PEDV-induced persistence would be reversible if viral replication was inhibited. Therefore, we performed time course experiments in which Vero cells were C. pecorum/PEDV infected in the presence of cycloheximide (CHX), which inhibits viral but not chlamydial protein synthesis. CHX-exposure inhibited PEDV replication, but did not inhibit induction of C. pecorum persistence at 24 h post-PEDV infection, as indicated by AB formation and reduced production of infectious EBs. Interestingly, production of infectious EBs resumed when CHX-exposed, co-infected cells were incubated 48-72 h post-PEDV co-infection. These data demonstrate that PEDV co-infection-induced chlamydial persistence/stress is reversible and suggest that this induction (i) does not require viral replication in host cells; and (ii) does not require de novo host or viral protein synthesis. These data also suggest that viral binding and/or entry may be required for this effect. Because the PEDV host cell receptor (CD13 or aminopeptidase N) stimulates cellular signaling pathways in the absence of PEDV infection, we suspect that PEDV co-infection might alter CD13 function and induce the chlamydiae to enter the persistent state.
|
6 |
Utilisation d'outils bio-informatiques pour l'étude de pathogènes émergents / Use of bioinformatics tools for the study of emerging pathogensBenamar, Samia 06 July 2017 (has links)
La recherche en bactériologie et virologie est à la fois de nature cognitive et appliquée. Elle consiste à fédérer et mettre en place une capacité de recherche multidisciplinaire et pouvoir l'intégrer sur un champ très vaste de microorganismes et de maladies. Les nouvelles avancées conceptuelles et technologiques dans le domaine de la génomique, notamment les avancées dans les techniques à haut débit (séquençage, PCR...) permettent actuellement d’avoir rapidement des génomes bactériens et viraux entiers, ou seulement sur quelques gènes d’une grande population. Les progrès dans ce domaine permettent l’accès à ces informations en évitant une combinaison de plusieurs méthodologies, et à moindre coûts. Dans notre travail de thèse, nous avons été porté à analyser et traiter les données de deux études genomiques et métagenomiques, mettant en évidence avantages, limites et attentes liés à ces techniques. La première étude porte sur l'analyse génomique de nouveaux virus géants et chlamydia infectant Vermamoeba vermiformis. La deuxième étude concerne le pyroséquençage 16S de microbiote intestinal de nouveau-nés atteint de l'entérocolite nécrosante. Pour le premier projet du travail de thèse, nous avons analysé les génomes de trois nouvelles espèces de Chlamydiae et onze virus giants (premiers membres de deux probables nouvelles familles) qui se multiplient naturellement dans Vermamoeba vermiformis. L'objectif étant de mettre en évidence les caractéristiques génétiques spécifiques à ces micro-organismes. La deuxième partie a été consacrée à l'analyse des données de pyroséquençage 16S des selles de nouveau-nés atteints de l'entérocolite nécrosante. / Research in bacteriology and virology is both cognitive and applied. It involves federating and developing a multidisciplinary research capacity and being able to integrate it into a very broad field of microorganisms and diseases. New genomic and conceptual advances in genomics, including advances in high-throughput techniques, now permit rapid bacterial and viral genomes, or only a few genes of a large population. Progress in this area allows access to this information by avoiding a combination of several methodologies and at lower costs. In our thesis work, we were led to analyze and process the data of two genomic and metagenomic studies, highlighting advantages, limitations and expectations related to these techniques. The first study focuses on the genomic analysis of new giant viruses and chlamydia infecting Vermamoeba vermiformis. The second study concerns the 16S pyrosequencing of intestinal microbiota of neonates with necrotizing enterocolitis. The first project of the thesis work analyzed the genomes of three new species of Chlamydiae and eleven giant viruses (first members of two probable new families) which naturally multiply in Vermamoeba vermiformis. The objective is to highlight the genetic characteristics specific to these microorganisms. The second part was devoted to the analysis of 16S pyrosequencing data from neonatal enterocolitis neonatal stools. The goal was to identify an agent responsible for this disease.
|
7 |
Host Nectin-1 Is Required for Efficient Chlamydia Trachomatis Serovar E DevelopmentHall, Jennifer V., Sun, Jingru, Slade, Jessica, Kintner, Jennifer, Bambino, Marissa, Whittimore, Judy, Schoborg, Robert V. 01 January 2014 (has links)
Interaction of Herpes Simplex Virus (HSV) glycoprotein D (gD) with the host cell surface during Chlamydia trachomatis/HSV co-infection stimulates chlamydiae to become persistent. During viral entry, gD interacts with one of 4 host co-receptors: HVEM (herpes virus entry mediator), nectin-1, nectin-2 and 3-O-sulfated heparan sulfate. HVEM and nectin-1 are high-affinity entry receptors for both HSV-1 and HSV-2. Nectin-2 mediates HSV-2 entry but is inactive for HSV-1, while 3-O-sulfated heparan sulfate facilitates HSV-1, but not HSV-2, entry. Western blot and RT-PCR analyses demonstrate that HeLa and HEC-1B cells express nectin-1 and nectin-2, but not HVEM. Because both HSV-1 and HSV-2 trigger persistence, these data suggest that nectin-1 is the most likely co-receptor involved. Co-infections with nectin-1 specific HSV-1 mutants stimulate chlamydial persistence, as evidenced by aberrant body (AB) formation and decreased production of elementary bodies (EBs). These data indicate that nectin-1 is involved in viral-induced chlamydial persistence. However, inhibition of signal transduction molecules associated with HSV attachment and entry does not rescue EB production during C. trachomatis/HSV-2 co-infection. HSV attachment also does not activate Cdc42 in HeLa cells, as would be expected with viral stimulated activation of nectin-1 signaling. Additionally, immunofluorescence assays confirm that HSV infection decreases nectin-1 expression. Together, these observations suggest that gD binding-induced loss of nectin-1 signaling negatively influences chlamydial growth. Chlamydial infection studies in nectin-1 knockdown (NKD) HeLa cell lines support this hypothesis. In NKD cells, chlamydial inclusions are smaller in size, contain ABs, and produce significantly fewer infectious EBs compared to C. trachomatis infection in control HeLa cells. Overall, the current study indicates that the actions of host molecule, nectin-1, are required for successful C. trachomatis development.
|
Page generated in 0.0338 seconds